Lung Cancer Information - December 2, 2008

New Cancer Cases In The U.S. Down 0.8 Percent From 1999 To 2005

November 26, 2008 - Topics cancer, colorectal cancer, lung cancer, smoking and male
There were 0.8 percent less new cases of cancer diagnosed in the U.S. from 1999 to 2005. At the same time, death rates due to cancer also went down 1.8 percent annually from 2002 to 2005, according to latest statistics.

By gender, there was significant decline in lung, prostate and colorectal cancer among males, while breast and colorectal cancer among females was noticeable

read more >>

U.S. Researchers Discover People Have Distinctive Scent That Doesn't Change

October 31, 2008 - Topics research, food, genetic, disease and immune
No matter what a person eats their basic scent, or body odor, remains detectably the same, researchers say.

It's serious research, because the same unique genes that determine body odor, called "odortypes," also in part are involved in the immune system, scientists from the Philadelphia, Pennsylvania-based nonprofit basic research institute Monell Center say

read more >>

Cancer Treatments Considered By Many American Patients Too Expensive

October 13, 2008 - Topics cancer, breast cancer, lung cancer, women and survey
One in eight patients with advanced stages of cancers did not push through anymore with treatments because of the soaring cost of health care, according to a new study.

USA Today quoted the study that one-fourth of cancer patients with incomes below $40,000 no longer pursued treatment. Those diagnosed with late-stage colon cancer had to spend over $25,000 out-of-pocket expenses, so only 12 percent of them sought medication

read more >>

Study: Genentech-Avastin Combination Does Not Boost Lung Cancer Survival

October 7, 2008 - Topics study, lung cancer, cancer, disease and studies
A large-scale clinical trial combining two popular lung cancer drugs Tarceva and Avastin has showed no increase in survival rates.

However, the combination treatment kept the disease from progressing for a longer period than Tarceva alone, the study found. Tarceva is marketed by Genentech and Avastin by Roche. Roche Holding AG sells both drugs in Europe

read more >>

Lung Disease To Kill 80 Million People In China, New Report Projects

October 4, 2008 - Topics disease, stress, pollution, research and education
More than 80 million people in China will die in the next 25 years from lung disease, a new study confirms. Researchers from the Harvard School of Public Health say the deaths would be attributed to smoking habits and the common practice of burning coal and wood for cooking and heating.

The study, which is published online on Saturday by the British journal The Lancet looked at a 30-year period, spanning the last five and the next 25. More than half of Chinese men population smoke and more than 70 percent of Chinese households use solid fuels that are a major source of indoor air pollution, the study says

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use